2025

New Antipsychotics 2025

New Antipsychotics 2025. The drug’s potential caught the eye of pharma giant bristol myers squibb, which announced a $14 billion deal to acquire karuna in december. Total revenues for the first quarter of 2024 were $47.5 million, a 24% decrease compared to.


New Antipsychotics 2025

Caplyta q1 2024 net product sales were $144.8 million, compared to $94.7 million for the same period in 2023, representing a 53% increase. Has developed a new combination drug called karxt.

New Antipsychotics 2025 Images References :